© Datamonitor the home of Business Intelligence intuitive deliveryexpert analysisquality data © Datamonitor

PharmaVitae: Takeda Pharmaceutical Co., Ltd HC Slidepack 11/11 quality dataexpert analysisintuitive delivery the home of Business Intelligence

Takeda prescription pharmaceutical performance, sales ($m) and growth rate (%), 2004–16

Takeda financial performance ($m), 2004–16

Takeda’s key product sales ($m), 2004–16

Takeda’s key product growth drivers and resistors ($m), 2004–10

Takeda’s key product growth drivers and resistors ($m), 2010–16

Takeda prescription pharmaceutical sales by therapy area ($m), 2004–16

Takeda prescription pharmaceutical sales by geographic region ($m), 2004–16

Takeda launch, core and expiry configuration, sales ($m), 2010–16

Takeda prescription pharmaceutical sales by molecule type ($m), 2004–16

Takeda prescription pharmaceutical sales by source of product ($m), 2004–16

Takeda operating revenue/cost analysis ($m), 2004–16

Blopress sales by geography and analyst consensus ($m), 2004–16

Lupron Depot sales by geography and analyst consensus ($m), 2004–16

Actos sales by geography and analyst consensus ($m), 2004–16

Liovel sales by geography and analyst consensus ($m), 2004–16

Enbrel sales by geography and analyst consensus ($m), 2004–16

Takepron sales by geography and analyst consensus ($m), 2004–16

Nesina sales by geography and analyst consensus ($m), 2004–16

Velcade sales by geography and analyst consensus ($m), 2004–16

© Datamonitor the home of Business Intelligence intuitive deliveryexpert analysisquality data © Datamonitor